Quick Answer
NeuroSense Therapeutics Ltd. reported Total Assets of $1.03 million for the year ending 2025.
- NeuroSense Therapeutics Ltd. showed a decrease of -77.5% in Total Assets from 2024 to 2025.
- This data is from NeuroSense Therapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), NeuroSense Therapeutics Ltd.'s Total Assets has grown by 32.0%.
- Historical annual values: Fiscal year 2025: $1.03 million | Fiscal year 2024: $4.58 million | Fiscal year 2023: $3.19 million | Fiscal year 2022: $7.71 million | Fiscal year 2021: $11.43 million | Fiscal year 2020: $779.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: